WHAT’S HAPPENING TODAY: Good afternoon and happy Thursday, Daily on Energy readers! We’re less than one week away from baby ...
Beleaguered Biogen has been handed some encouraging news from the FDA, after the regulator agreed to complete its review of amyotrophic lateral sclerosis (ALS) therapy tofersen within six months. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results